EAN 2024 | The challenges with implementing transcranial electrical brain stimulation into clinical practice

Andrea Antal, MD, PhD, University of Goettingen, Göttingen, Germany, comments on the challenges of translating transcranial electrical brain stimulation (tES) clinical trial protocols into real-world practice, emphasizing patient variability and the need for individualized treatment approaches. She outlines the patient groups who should not receive tES (e.g., individuals with metal implants) and discusses the logistical barriers to implementing tES, highlighting the need to develop at-home stimulation devices. This interview took place at the European Academy of Neurology (EAN) Annual Meeting 2024 in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.